Literature DB >> 9098283

Baseline characteristics, natural history, and risk factors to progression in eyes with stage 2 macular holes. Results from a prospective randomized clinical trial. Vitrectomy for Macular Hole Study Group.

J W Kim1, W R Freeman, W el-Haig, A M Maguire, J F Arevalo, S P Azen.   

Abstract

PURPOSE: The purpose of this study is (1) to determine baseline characteristics and natural history of immature full-thickness macular holes, (2) to describe progression and resolution, and (3) to present new aspects of pathogenesis of idiopathic macular hole.
METHODS: The authors analyzed 41 eyes with stage 2 macular holes (37 patients) in a multicentered prospective randomized trial; 19 eyes were randomized to observation (versus surgery) and had more than 12 months of follow-up, allowing determination of the natural course. Baseline and subsequent examinations included best-refracted visual acuity (Early Treatment of Diabetic Retinopathy Study, potential acuity meter, Pelli-Robson contrast sensitivity, and Bailey-Lovie reading vision), of clinical examinations, photography, and fluorescein angiography. RESULT: Mean Snellen visual acuity was 20/66 at baseline. Centric holes usually had a small break (201 microns average mean diameter) with a dark yellow ring and without significant retinal elevation. Eccentric holes had a high maximum/minimum diameter ratio (mean, 1.88 +/- 0.7) and an incomplete cuff of subretinal fluid or yellow ring. Posterior vitreous detachment prevalence was 32% (8/25) in the centric hole group and 0% (0/ 16) in the eccentric hole group (P < 0.05). For the 19 eyes with 12 months of followup, progression rate to stage 3 (or 4) was 74% (n = 14). The diameter of the stage 2 holes increased significantly between baseline and 12 months (P < 0.001). Progression rate to stage 3 was 100% (8/8) in the eyes with pericentral hyperfluorescence (PCH) and 55% (6/11) in eyes without PCH (P < 0.05). Enlargement occurred in 100% of eccentric holes and 60% of centric holes (P = 0.09). Different progression patterns in eccentric and centric holes suggest different mechanisms of pathogenesis.
CONCLUSION: Eccentric and centric stage 2 macular holes may have a different pathogenesis. Most stage 2 macular holes, especially with PCH (P < 0.05) or eccentric holes, progressed to stage 3 or 4. In addition to purely tangential traction, some component of obliquely oriented anteroposterior vitreous traction component may be important for pathogenesis of senile macular holes, particularly eccentric stage 2 macular holes.

Entities:  

Mesh:

Year:  1995        PMID: 9098283     DOI: 10.1016/s0161-6420(95)30788-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  11 in total

Review 1.  Idiopathic full thickness macular hole: natural history and pathogenesis.

Authors:  E Ezra
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

Review 2.  [Macular hole. Survey and relevant surgical concepts].

Authors:  S Dithmar
Journal:  Ophthalmologe       Date:  2005-02       Impact factor: 1.059

3.  Idiopathic macular holes and direction of vitreomacular traction: structural changes and surgical outcomes.

Authors:  C-Y Tsai; Y-T Hsieh; T-T Lai; C-M Yang
Journal:  Eye (Lond)       Date:  2017-07-21       Impact factor: 3.775

4.  Focal vitreomacular traction: a prospective study of the evolution to macular hole: the mathematical approach.

Authors:  G Theodossiadis; P Petrou; M Eleftheriadou; A L Moustakas; I Datseris; P Theodossiadis
Journal:  Eye (Lond)       Date:  2014-09-19       Impact factor: 3.775

5.  Clinical findings in macular hole surgery with indocyanine green-assisted peeling of the internal limiting membrane.

Authors:  S Wolf; M B Reichel; P Wiedemann; U E K Schnurrbusch
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-05-08       Impact factor: 3.117

6.  A retrospective cohort study in patients with tractional diseases of the vitreomacular interface (ReCoVit).

Authors:  Peter Stalmans
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-02-22       Impact factor: 3.117

7.  Prognostic Factors Associated with Ocriplasmin Efficacy for the Treatment of Symptomatic Vitreomacular Adhesion and Full-thickness Macular Hole: Analysis from Four Studies.

Authors:  Brian C Joondeph; Paul Willems; Thomas Raber; Luc Duchateau; Joseph Markoff
Journal:  J Ophthalmic Vis Res       Date:  2021-01-20

8.  Spontaneous Closure of a Full-Thickness Stage 2 Idiopathic Macular Hole without Posterior Vitreous Detachment.

Authors:  Aditya Shreekant Kelkar; Devanshi Ramji Bhanushali; Jai Aditya Kelkar; Rachana Bharat Shah; Shreekant Bhaskar Kelkar
Journal:  Case Rep Ophthalmol       Date:  2013-10-23

Review 9.  Optimal management of idiopathic macular holes.

Authors:  Haifa A Madi; Ibrahim Masri; David H Steel
Journal:  Clin Ophthalmol       Date:  2016-01-13

10.  A Comparative Study of Vitrectomy Combined with Internal Limiting Membrane Peeling for the Treatment of Idiopathic Macular Hole with Air or C3F8 Intraocular Tamponade.

Authors:  Xiang Chen; Yi Yao; Xiaolu Hao; Xiaocui Liu; Tiecheng Liu
Journal:  J Ophthalmol       Date:  2018-07-02       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.